APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tablet and Capsule Budesonide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tablet and Capsule Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchTablet and Capsule Budesonide Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Tablet and Capsule Budesonide Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Tablet and Capsule Budesonide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tablet and Capsule Budesonide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Tablet and Capsule Budesonide Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Tablet and Capsule Budesonide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tablet and Capsule Budesonide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tablet and Capsule Budesonide include Chiesi Farmaceutici, Cipla, Cosmo Pharmaceuticals, Orion Corporation, Salix, AstraZeneca, Synmosa Biopharma, Lunan Better Pharma and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tablet and Capsule Budesonide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tablet and Capsule Budesonide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tablet and Capsule Budesonide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tablet and Capsule Budesonide market size, projected growth trends, production technologies, key applications, and end-use industries.

Tablet and Capsule Budesonide Segment by Company

Chiesi Farmaceutici

Cipla

Cosmo Pharmaceuticals

Orion Corporation

Salix

AstraZeneca

Synmosa Biopharma

Lunan Better Pharma

Mylan

Sandoz

Shanghai Sine Promod

Teva

Tablet and Capsule Budesonide Segment by Type

Tablet

Capsule

Tablet and Capsule Budesonide Segment by Application

Inflammatory Bowel Disease Treatment

Respiratory Disease Treatment

Nose Disease Treatment

Other

Tablet and Capsule Budesonide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tablet and Capsule Budesonide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tablet and Capsule Budesonide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tablet and Capsule Budesonide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tablet and Capsule Budesonide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tablet and Capsule Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tablet and Capsule Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tablet and Capsule Budesonide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tablet and Capsule Budesonide Industry Trends Table 2. Tablet and Capsule Budesonide Industry Drivers Table 3. Tablet and Capsule Budesonide Industry Opportunities and Challenges Table 4. Tablet and Capsule Budesonide Industry Restraints Table 5. Global Tablet and Capsule Budesonide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tablet and Capsule Budesonide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tablet and Capsule Budesonide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tablet and Capsule Budesonide Sales Market Share by Manufacturers Table 9. Global Tablet and Capsule Budesonide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tablet and Capsule Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tablet and Capsule Budesonide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tablet and Capsule Budesonide Manufacturers, Product Type & Application Table 13. Global Tablet and Capsule Budesonide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tablet and Capsule Budesonide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Capsule Table 18. Global Tablet and Capsule Budesonide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tablet and Capsule Budesonide Sales by Type (2021-2026) & (K Units) Table 20. Global Tablet and Capsule Budesonide Sales by Type (2027-2032) & (K Units) Table 21. Global Tablet and Capsule Budesonide Sales Market Share by Type (2021-2026) Table 22. Global Tablet and Capsule Budesonide Sales Market Share by Type (2027-2032) Table 23. Global Tablet and Capsule Budesonide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tablet and Capsule Budesonide Revenue by Type (2021-2026) & (K Units) Table 25. Global Tablet and Capsule Budesonide Revenue by Type (2027-2032) & (K Units) Table 26. Global Tablet and Capsule Budesonide Revenue Market Share by Type (2021-2026) Table 27. Global Tablet and Capsule Budesonide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Inflammatory Bowel Disease Treatment Table 29. Major Manufacturers of Respiratory Disease Treatment Table 30. Major Manufacturers of Nose Disease Treatment Table 31. Major Manufacturers of Other Table 32. Global Tablet and Capsule Budesonide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Tablet and Capsule Budesonide Sales by Application (2021-2026) & (K Units) Table 34. Global Tablet and Capsule Budesonide Sales by Application (2027-2032) & (K Units) Table 35. Global Tablet and Capsule Budesonide Sales Market Share by Application (2021-2026) Table 36. Global Tablet and Capsule Budesonide Sales Market Share by Application (2027-2032) Table 37. Global Tablet and Capsule Budesonide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Tablet and Capsule Budesonide Revenue by Application (2021-2026) & (K Units) Table 39. Global Tablet and Capsule Budesonide Revenue by Application (2027-2032) & (K Units) Table 40. Global Tablet and Capsule Budesonide Revenue Market Share by Application (2021-2026) Table 41. Global Tablet and Capsule Budesonide Revenue Market Share by Application (2027-2032) Table 42. Global Tablet and Capsule Budesonide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Tablet and Capsule Budesonide Sales by Region (2021-2026) & (K Units) Table 44. Global Tablet and Capsule Budesonide Sales Market Share by Region (2021-2026) Table 45. Global Tablet and Capsule Budesonide Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Tablet and Capsule Budesonide Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 49. North America Tablet and Capsule Budesonide Sales by Country (2027-2032) & (K Units) Table 50. Europe Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 52. Europe Tablet and Capsule Budesonide Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Tablet and Capsule Budesonide Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2027-2032) & (K Units) Table 59. Global Tablet and Capsule Budesonide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Tablet and Capsule Budesonide Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Tablet and Capsule Budesonide Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Tablet and Capsule Budesonide Revenue Market Share by Region (2021-2026) Table 63. Global Tablet and Capsule Budesonide Revenue Market Share by Region (2027-2032) Table 64. Chiesi Farmaceutici Company Information Table 65. Chiesi Farmaceutici Business Overview Table 66. Chiesi Farmaceutici Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio Table 68. Chiesi Farmaceutici Recent Development Table 69. Cipla Company Information Table 70. Cipla Business Overview Table 71. Cipla Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Cipla Tablet and Capsule Budesonide Product Portfolio Table 73. Cipla Recent Development Table 74. Cosmo Pharmaceuticals Company Information Table 75. Cosmo Pharmaceuticals Business Overview Table 76. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio Table 78. Cosmo Pharmaceuticals Recent Development Table 79. Orion Corporation Company Information Table 80. Orion Corporation Business Overview Table 81. Orion Corporation Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Orion Corporation Tablet and Capsule Budesonide Product Portfolio Table 83. Orion Corporation Recent Development Table 84. Salix Company Information Table 85. Salix Business Overview Table 86. Salix Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Salix Tablet and Capsule Budesonide Product Portfolio Table 88. Salix Recent Development Table 89. AstraZeneca Company Information Table 90. AstraZeneca Business Overview Table 91. AstraZeneca Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. AstraZeneca Tablet and Capsule Budesonide Product Portfolio Table 93. AstraZeneca Recent Development Table 94. Synmosa Biopharma Company Information Table 95. Synmosa Biopharma Business Overview Table 96. Synmosa Biopharma Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio Table 98. Synmosa Biopharma Recent Development Table 99. Lunan Better Pharma Company Information Table 100. Lunan Better Pharma Business Overview Table 101. Lunan Better Pharma Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio Table 103. Lunan Better Pharma Recent Development Table 104. Mylan Company Information Table 105. Mylan Business Overview Table 106. Mylan Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Mylan Tablet and Capsule Budesonide Product Portfolio Table 108. Mylan Recent Development Table 109. Sandoz Company Information Table 110. Sandoz Business Overview Table 111. Sandoz Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Sandoz Tablet and Capsule Budesonide Product Portfolio Table 113. Sandoz Recent Development Table 114. Shanghai Sine Promod Company Information Table 115. Shanghai Sine Promod Business Overview Table 116. Shanghai Sine Promod Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio Table 118. Shanghai Sine Promod Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva Tablet and Capsule Budesonide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Teva Tablet and Capsule Budesonide Product Portfolio Table 123. Teva Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Tablet and Capsule Budesonide Distributors List Table 127. Tablet and Capsule Budesonide Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Tablet and Capsule Budesonide Product Image Figure 2. Global Tablet and Capsule Budesonide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tablet and Capsule Budesonide Market Size (2021-2032) & (US$ Million) Figure 4. Global Tablet and Capsule Budesonide Sales (2021-2032) & (K Units) Figure 5. Global Tablet and Capsule Budesonide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tablet and Capsule Budesonide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Capsule Image Figure 10. Global Tablet and Capsule Budesonide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tablet and Capsule Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tablet and Capsule Budesonide Sales Market Share by Type (2021-2032) Figure 13. Global Tablet and Capsule Budesonide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tablet and Capsule Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tablet and Capsule Budesonide Revenue Market Share by Type (2021-2032) Figure 16. Inflammatory Bowel Disease Treatment Image Figure 17. Respiratory Disease Treatment Image Figure 18. Nose Disease Treatment Image Figure 19. Other Image Figure 20. Global Tablet and Capsule Budesonide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Tablet and Capsule Budesonide Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Tablet and Capsule Budesonide Sales Market Share by Application (2021-2032) Figure 23. Global Tablet and Capsule Budesonide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Tablet and Capsule Budesonide Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tablet and Capsule Budesonide Revenue Market Share by Application (2021-2032) Figure 26. North America Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Tablet and Capsule Budesonide Sales Market Share by Country (2021-2032) Figure 28. U.S. Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Tablet and Capsule Budesonide Sales Market Share by Country (2021-2032) Figure 33. Germany Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Tablet and Capsule Budesonide Sales Market Share by Country (2021-2032) Figure 40. China Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Tablet and Capsule Budesonide Sales Market Share by Country (2021-2032) Figure 48. Brazil Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Tablet and Capsule Budesonide Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Tablet and Capsule Budesonide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Tablet and Capsule Budesonide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Tablet and Capsule Budesonide Revenue (2021-2032) & (US$ Million) Figure 59. North America Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Tablet and Capsule Budesonide Revenue (2021-2032) & (US$ Million) Figure 61. Europe Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Tablet and Capsule Budesonide Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Tablet and Capsule Budesonide Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Tablet and Capsule Budesonide Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Tablet and Capsule Budesonide Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
Applications
  • Inflammatory Bowel Disease Treatment
  • Respiratory Disease Treatment
  • Nose Disease Treatment
  • Other
Companies covered
  • Chiesi Farmaceutici
  • Cipla
  • Cosmo Pharmaceuticals
  • Orion Corporation
  • Salix
  • AstraZeneca
  • Synmosa Biopharma
  • Lunan Better Pharma
  • Mylan
  • Sandoz
  • Shanghai Sine Promod
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tablet and Capsule Budesonide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tablet and Capsule Budesonide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tablet and Capsule Budesonide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tablet and Capsule Budesonide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tablet and Capsule Budesonide Market Dynamics
  1. 2.1 Tablet and Capsule Budesonide Industry Trends
  2. 2.2 Tablet and Capsule Budesonide Industry Drivers
  3. 2.3 Tablet and Capsule Budesonide Industry Opportunities and Challenges
  4. 2.4 Tablet and Capsule Budesonide Industry Restraints
3 Tablet and Capsule Budesonide Market by Manufacturers
  1. 3.1 Global Tablet and Capsule Budesonide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tablet and Capsule Budesonide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tablet and Capsule Budesonide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tablet and Capsule Budesonide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tablet and Capsule Budesonide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tablet and Capsule Budesonide Manufacturers, Product Type & Application
  7. 3.7 Global Tablet and Capsule Budesonide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tablet and Capsule Budesonide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tablet and Capsule Budesonide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tablet and Capsule Budesonide Tier 1, Tier 2, and Tier 3
4 Tablet and Capsule Budesonide Market by Type
  1. 4.1 Tablet and Capsule Budesonide Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.2 Global Tablet and Capsule Budesonide Sales by Type
  5. 4.2.1 Global Tablet and Capsule Budesonide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tablet and Capsule Budesonide Sales by Type (2021-2032)
  7. 4.2.3 Global Tablet and Capsule Budesonide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tablet and Capsule Budesonide Revenue by Type
  9. 4.3.1 Global Tablet and Capsule Budesonide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tablet and Capsule Budesonide Revenue by Type (2021-2032)
  11. 4.3.3 Global Tablet and Capsule Budesonide Revenue Market Share by Type (2021-2032)
5 Tablet and Capsule Budesonide Market by Application
  1. 5.1 Tablet and Capsule Budesonide Application Introduction
  2. 5.1.1 Inflammatory Bowel Disease Treatment
  3. 5.1.2 Respiratory Disease Treatment
  4. 5.1.3 Nose Disease Treatment
  5. 5.1.4 Other
  6. 5.2 Global Tablet and Capsule Budesonide Sales by Application
  7. 5.2.1 Global Tablet and Capsule Budesonide Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Tablet and Capsule Budesonide Sales by Application (2021-2032)
  9. 5.2.3 Global Tablet and Capsule Budesonide Sales Market Share by Application (2021-2032)
  10. 5.3 Global Tablet and Capsule Budesonide Revenue by Application
  11. 5.3.1 Global Tablet and Capsule Budesonide Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Tablet and Capsule Budesonide Revenue by Application (2021-2032)
  13. 5.3.3 Global Tablet and Capsule Budesonide Revenue Market Share by Application (2021-2032)
6 Global Tablet and Capsule Budesonide Sales by Region
  1. 6.1 Global Tablet and Capsule Budesonide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tablet and Capsule Budesonide Sales by Region (2021-2032)
  3. 6.2.1 Global Tablet and Capsule Budesonide Sales by Region (2021-2026)
  4. 6.2.2 Global Tablet and Capsule Budesonide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tablet and Capsule Budesonide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tablet and Capsule Budesonide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tablet and Capsule Budesonide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tablet and Capsule Budesonide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tablet and Capsule Budesonide Revenue by Region
  1. 7.1 Global Tablet and Capsule Budesonide Revenue by Region
  2. 7.1.1 Global Tablet and Capsule Budesonide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tablet and Capsule Budesonide Revenue by Region (2021-2026)
  4. 7.1.3 Global Tablet and Capsule Budesonide Revenue by Region (2027-2032)
  5. 7.1.4 Global Tablet and Capsule Budesonide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tablet and Capsule Budesonide Revenue (2021-2032)
  8. 7.2.2 North America Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tablet and Capsule Budesonide Revenue (2021-2032)
  11. 7.3.2 Europe Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tablet and Capsule Budesonide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tablet and Capsule Budesonide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tablet and Capsule Budesonide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiesi Farmaceutici
  2. 8.1.1 Chiesi Farmaceutici Company Information
  3. 8.1.2 Chiesi Farmaceutici Business Overview
  4. 8.1.3 Chiesi Farmaceutici Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio
  6. 8.1.5 Chiesi Farmaceutici Recent Developments
  7. 8.2 Cipla
  8. 8.2.1 Cipla Company Information
  9. 8.2.2 Cipla Business Overview
  10. 8.2.3 Cipla Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cipla Tablet and Capsule Budesonide Product Portfolio
  12. 8.2.5 Cipla Recent Developments
  13. 8.3 Cosmo Pharmaceuticals
  14. 8.3.1 Cosmo Pharmaceuticals Company Information
  15. 8.3.2 Cosmo Pharmaceuticals Business Overview
  16. 8.3.3 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio
  18. 8.3.5 Cosmo Pharmaceuticals Recent Developments
  19. 8.4 Orion Corporation
  20. 8.4.1 Orion Corporation Company Information
  21. 8.4.2 Orion Corporation Business Overview
  22. 8.4.3 Orion Corporation Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Orion Corporation Tablet and Capsule Budesonide Product Portfolio
  24. 8.4.5 Orion Corporation Recent Developments
  25. 8.5 Salix
  26. 8.5.1 Salix Company Information
  27. 8.5.2 Salix Business Overview
  28. 8.5.3 Salix Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Salix Tablet and Capsule Budesonide Product Portfolio
  30. 8.5.5 Salix Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Tablet and Capsule Budesonide Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 Synmosa Biopharma
  38. 8.7.1 Synmosa Biopharma Company Information
  39. 8.7.2 Synmosa Biopharma Business Overview
  40. 8.7.3 Synmosa Biopharma Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio
  42. 8.7.5 Synmosa Biopharma Recent Developments
  43. 8.8 Lunan Better Pharma
  44. 8.8.1 Lunan Better Pharma Company Information
  45. 8.8.2 Lunan Better Pharma Business Overview
  46. 8.8.3 Lunan Better Pharma Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio
  48. 8.8.5 Lunan Better Pharma Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Tablet and Capsule Budesonide Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Sandoz
  56. 8.10.1 Sandoz Company Information
  57. 8.10.2 Sandoz Business Overview
  58. 8.10.3 Sandoz Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sandoz Tablet and Capsule Budesonide Product Portfolio
  60. 8.10.5 Sandoz Recent Developments
  61. 8.11 Shanghai Sine Promod
  62. 8.11.1 Shanghai Sine Promod Company Information
  63. 8.11.2 Shanghai Sine Promod Business Overview
  64. 8.11.3 Shanghai Sine Promod Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio
  66. 8.11.5 Shanghai Sine Promod Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Tablet and Capsule Budesonide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Tablet and Capsule Budesonide Product Portfolio
  72. 8.12.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tablet and Capsule Budesonide Value Chain Analysis
  2. 9.1.1 Tablet and Capsule Budesonide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tablet and Capsule Budesonide Production Mode & Process
  6. 9.2 Tablet and Capsule Budesonide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tablet and Capsule Budesonide Distributors
  9. 9.2.3 Tablet and Capsule Budesonide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst